Recrudescence of treated neurosyphilis in a patient with human immunodeficiency virus

Mayo Clinic Proceedings

Volumn 74, Issue 1, 1999, Pages 53-56

  Dibbern Jr , Donald A ^a   Ray, Stuart C ^b  

^a Department of Medicine ^*  (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN; PENICILLIN G;

ADULT; ARTICLE; CASE REPORT; COMORBIDITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEUROSYPHILIS; RASH; RECURRENT INFECTION; SEXUALLY TRANSMITTED DISEASE; TREATMENT FAILURE; TREPONEMA PALLIDUM;

EID: 0032946882     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/74.1.53     Document Type: Article

References (14)

1. Rowland LP. Spirochete infections: neurosyphilis. In: Rowland LP, editor. Memtt's Textbook of Neurology. 8th ed. Philadelphia: Lea & Febiger; 1989. pp 152-161
2. Scheck DN, Hook EW III. Neurosyphilis. Infect Dis Clin North Am 1994 Dec;8:769-795
3. Sanford JP, Gilbert DN, Moellering RC Jr, Sande MA. The Sanford Guide to Antimicrobial Therapy 1997. 27th ed. Vienna (VA): Antimicrobial Therapy; 1997. p 16
4. Richards BW, Hessburg TJ, Nussbaum JN. Recurrent syphilitic uveitis [letter]. N EnglJ Med 1989;320:62
5. Berry CD, Hooton TM, Collier AC, Lukehart SA. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987;316:1587-1589
6. Gregory N, Sanchez M, Buchness MR. The spectrum of syphilis in patients with human immunodeficiency virus infection. J Am Acad Dermatol 1990;22:1061-1067
7. Malone JL, Wallace MR, Hendrick BB, LaRocco A Jr, Tonon E, Brodlne SK, et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent sérologie relapse after therapy. Am J Med 1995;99:55-63
8. Centers for Disease Control and Prevention. Outbreak of primary and secondary syphilis-Baltimore City, Maryland, 1995. MMWR Morb Mortal Wkly Rep 1996;45:166-169
9. Hutchinson CM, Rompalo AM, Reichart CA, Hook EW III. Characteristics of patients with syphilis attending Baltimore STD clinics: multiple high-risk subgroups and interactions with human immunodeficiency virus infection. Arch Intern Med 1991;151:511-516
10. Quinn TC, Cannon RO, Classer D, Groseclose SL, Brathwaite WS, Fauci AS, et al. The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Arch Intern Med 1990;150:1297-1302
11. Nelson KE, Vlahov D, Cohn S, Odunmbaku M, Lindsay A, Anthony JC, et al. Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV). J Infect Dis 1991;164:457-463
12. Musher DM, Hamill RJ, Baughn RE. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med 1990:113:872-881
13. Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997:337:307-314
14. Fernândez-Guerrero ML, Miranda C, Cenjor C, Sanabria F. The treatment of neurosyphilis in patients with HIV infection [letter]. JAMA 1988:259:1495-1496